Details
Product Name in the RMS: Triveram 20 mg/10 mg/5 mg
MR Number: FI/H/0840/003
Date of outcome: 23.07.2015
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Known Active Substance Initial Application Fixed Combination Chemical Substance Prescription Only |
Active Substances |
amlodipine besilate 6,94 mg atorvastatin calcium 21,64 mg perindopril arginine salt 10 mg |
Form | Film coated tablet |
MA Holder in the RMS |
Les Laboratoires Servier 50 rue Carnot 92284 Suresnes Cedex France |
RMS | Finland |
Date of last change | 05.11.2020 |
ATC-Code |
C10BX11 atorvastatin, amlodipine and perindopril |
CMS Country | Domestic Product Name |
---|---|
Austria | Triveram 20 mg/10 mg/5 mg Filmtabletten |
Belgium | LIPERTANCE 20mg/10mg/5mg comprimé pelliculé |
Croatia | Lipertance 20 mg/10 mg/5 mg filmom obložene tablete |
Cyprus | PROALTA FCTABS |
Czech Republic | LIPERTANCE 20 MG/10 MG/5 MG |
Estonia | TRIVERAM 20MG/10MG/5MG |
France | |
Germany | Proalta 20 mg/5 mg/10 mg Filmtabletten |
Greece | TRIVERAM (ex PROALTA) |
Ireland | |
Italy | |
Latvia | Triveram 20 mg/10 mg/5 mg apvalkotās tabletes |
Lithuania | TRIVERAM 20 mg/10 mg/5 mg plėvele dengtos tabletės |
Luxembourg | |
Malta | |
Netherlands | Triveram 20mg/10mg/5mg filmomhulde tabletten |
Portugal | |
Romania | Lipertance 20 mg/5 mg/10 mg comprimate filmate |
Slovak Republic | Lipertance 20 mg/10 mg/5 mg |
Slovenia |
Documents | |
---|---|
PAR: | FI_H_0840_003_PAR.pdf (11.01.2016) |
Finalised Product Information: | FI_H_0840_003_FinalPI_1of4.pdf (01.11.2019) |
Finalised Product Information: | FI_H_0840_003_FinalPI_2of4.pdf (01.11.2019) |
Finalised Product Information: | FI_H_0840_003_FinalPI_3of4.pdf (01.11.2019) |
Finalised Product Information: | FI_H_0840_003_FinalPI_4of4.pdf (01.11.2019) |